PortfoliosLab logo
HUM vs. CI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HUM and CI is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HUM vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Humana Inc. (HUM) and Cigna Corporation (CI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HUM:

-0.79

CI:

-0.31

Sortino Ratio

HUM:

-0.90

CI:

-0.33

Omega Ratio

HUM:

0.87

CI:

0.96

Calmar Ratio

HUM:

-0.55

CI:

-0.37

Martin Ratio

HUM:

-1.18

CI:

-0.82

Ulcer Index

HUM:

27.34%

CI:

12.16%

Daily Std Dev

HUM:

42.60%

CI:

27.43%

Max Drawdown

HUM:

-85.10%

CI:

-84.34%

Current Drawdown

HUM:

-58.63%

CI:

-15.04%

Fundamentals

Market Cap

HUM:

$27.82B

CI:

$81.04B

EPS

HUM:

$14.17

CI:

$17.93

PE Ratio

HUM:

16.26

CI:

16.92

PEG Ratio

HUM:

0.70

CI:

0.59

PS Ratio

HUM:

0.23

CI:

0.32

PB Ratio

HUM:

1.56

CI:

2.00

Total Revenue (TTM)

HUM:

$120.26B

CI:

$254.47B

Gross Profit (TTM)

HUM:

$120.26B

CI:

$254.47B

EBITDA (TTM)

HUM:

$4.12B

CI:

$11.02B

Returns By Period

In the year-to-date period, HUM achieves a -10.05% return, which is significantly lower than CI's 12.40% return. Over the past 10 years, HUM has underperformed CI with an annualized return of 3.34%, while CI has yielded a comparatively higher 9.61% annualized return.


HUM

YTD

-10.05%

1M

-20.68%

6M

-19.12%

1Y

-33.69%

5Y*

-9.91%

10Y*

3.34%

CI

YTD

12.40%

1M

-6.02%

6M

-3.77%

1Y

-8.48%

5Y*

11.86%

10Y*

9.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HUM vs. CI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HUM
The Risk-Adjusted Performance Rank of HUM is 1414
Overall Rank
The Sharpe Ratio Rank of HUM is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of HUM is 1414
Sortino Ratio Rank
The Omega Ratio Rank of HUM is 1212
Omega Ratio Rank
The Calmar Ratio Rank of HUM is 1616
Calmar Ratio Rank
The Martin Ratio Rank of HUM is 1818
Martin Ratio Rank

CI
The Risk-Adjusted Performance Rank of CI is 2828
Overall Rank
The Sharpe Ratio Rank of CI is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of CI is 2626
Sortino Ratio Rank
The Omega Ratio Rank of CI is 2626
Omega Ratio Rank
The Calmar Ratio Rank of CI is 2626
Calmar Ratio Rank
The Martin Ratio Rank of CI is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HUM vs. CI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Humana Inc. (HUM) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HUM Sharpe Ratio is -0.79, which is lower than the CI Sharpe Ratio of -0.31. The chart below compares the historical Sharpe Ratios of HUM and CI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HUM vs. CI - Dividend Comparison

HUM's dividend yield for the trailing twelve months is around 1.56%, less than CI's 1.85% yield.


TTM20242023202220212020201920182017201620152014
HUM
Humana Inc.
1.56%1.40%0.77%0.62%0.60%0.61%0.60%0.70%0.76%0.43%0.64%0.77%
CI
Cigna Corporation
1.85%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%0.04%

Drawdowns

HUM vs. CI - Drawdown Comparison

The maximum HUM drawdown since its inception was -85.10%, roughly equal to the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for HUM and CI. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HUM vs. CI - Volatility Comparison

Humana Inc. (HUM) has a higher volatility of 15.90% compared to Cigna Corporation (CI) at 8.70%. This indicates that HUM's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HUM vs. CI - Financials Comparison

This section allows you to compare key financial metrics between Humana Inc. and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B30.00B40.00B50.00B60.00B70.00B20212022202320242025
32.11B
65.50B
(HUM) Total Revenue
(CI) Total Revenue
Values in USD except per share items

HUM vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between Humana Inc. and Cigna Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
100.0%
100.0%
(HUM) Gross Margin
(CI) Gross Margin
HUM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Humana Inc. reported a gross profit of 32.11B and revenue of 32.11B. Therefore, the gross margin over that period was 100.0%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a gross profit of 65.50B and revenue of 65.50B. Therefore, the gross margin over that period was 100.0%.

HUM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Humana Inc. reported an operating income of 2.01B and revenue of 32.11B, resulting in an operating margin of 6.3%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported an operating income of 1.65B and revenue of 65.50B, resulting in an operating margin of 2.5%.

HUM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Humana Inc. reported a net income of 1.24B and revenue of 32.11B, resulting in a net margin of 3.9%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a net income of 1.32B and revenue of 65.50B, resulting in a net margin of 2.0%.